BIT
SLS icon

BlackRock Institutional Trust’s SELLAS Life Sciences SLS Stock Holding History

BlackRock Institutional Trust’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$427K Buy
+147
New +$855K ﹤0.01% 3488

Other funds holding SLS

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock Institutional Trust's SLS Position: Q4 2016 in Review

BlackRock Institutional Trust opened a new position in SELLAS Life Sciences (SLS) in Q4 2016: 147 shares worth $427K. The stake represents ﹤0.01% of the portfolio and ranks #3488 among its holdings.

44 funds tracked by Wall St. Rank hold SLS as of Q4 2016.

  • BlackRock Institutional Trust held 147 shares of SELLAS Life Sciences worth $427K as of Q4 2016.
  • SELLAS Life Sciences was a new BlackRock Institutional Trust position in Q4 2016.
  • SELLAS Life Sciences made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #3488 holding.
  • 44 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.